Bionik Laboratories Corp announces it is working with IBM to develop a cognitive computing analytical system to improve outcomes of neurological rehabilitation.
“This collaboration is the genesis of a meeting nearly a year ago where we discussed the universal importance of big data. During our follow-on conversations, we began to realize synergies and started to discuss potential ways in which we could work together to develop an intelligent analytics platform for ARKE,” says Bionik co-founder and CEO Michal Prywata, in a company news release.
With this collaboration, the use of IBM’s cognitive computing infrastructure would enable access to Bionik’s ARKE robotic lower-body exoskeleton’s performance, patient data, and results of ARKE rehabilitation from multiple sites, including rehabilitation centers, physicians’ offices, physiotherapists’ offices, patients’ homes, research centers or any other location at any time, the release explains.
Phase one of the project will include the full backend required to capture the information needed for future use. In phases two and three, Bionik engineers together with data scientists at IBM will develop machine-learning algorithms designed to analyze large volumes of sensor data generated by ARKE, the release continues.
Leon Katsnelson, director and chief technology officer of IBM Analytic Platform Emerging Technologies, comments in the release that, “IBM recognizes the potential of Bionik’s ARKE exoskeleton and is eager to assist Bionik in their quest to provide advanced data analytics to rehabilitation specialists anywhere, anytime, through IBM Cloud.”
For more information, visit Bionik Laboratories Corp.
[Source(s): Bionik Laboratories Corp]
